Gala to raise funds for phase 1 cancer trials unit Feb 16, 2017 The annual Partnership Gala will benefit the Dan L Duncan Comprehensive Cancer Center and honor the work and career of its director, Dr. C Kent Osborne.
Scalp cooling effective in reducing hair loss during chemo Feb 14, 2017 Dr. Julie Nangia reports the results of her research studying the effectiveness of scalp cooling therapy in reducing hair loss in women undergoing chemotherapy.
Researcher contributes to project to help cancer diagnosis Jan 26, 2017 An international research group including Baylor College of Medicine has received a Catalyst Award to investigate ways of bringing new and improved cancer diagnostic tests to primary care practitioners.
Study shows link between Hepatitis C virus, multiple cancers Jan 26, 2017 Dr. Jennifer Kramer and colleagues examine the link between HCV and other cancers within the U.S. elderly population.
'Listening' to single cells may uncover cancer origins Jan 17, 2017 Baylor scientists have developed a method that allows them to accurately determine the genes expressed in single cells.
Baylor, nation’s cancer centers endorse updated HPV vaccine recommendations Jan 11, 2017 Baylor and the other 69 National Cancer Institute-designated cancer centers endorsed recently revised recommendations from the CDC on the need to improve vaccination rates for HPV.
Breast cancer researchers receive $900,000 to support study of treatment resistance, drug efficacy Dec 28, 2016 Dr. Meghashyam Kavuri and Dr. Xi Chen have been awarded grants from the Susan G. Komen Foundation to support their breast cancer research.
Mesothelioma Treatment Center opens study of new treatment Dec 20, 2016 The Mesothelioma Treatment Center has begun enrolling patients in a clinical research study for patients with malignant pleural mesothelioma.
Scalp-cooling device cuts hair loss in breast cancer patients undergoing chemotherapy Dec 9, 2016 A scalp cooling cap has been shown to effective in reducing hair loss in breast cancer patients undergoing chemotherapy.
Promising results shown from combination therapy in HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer Dec 8, 2016 A new study reveals the efficacy and safety of treating HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer with pertuzumab in combination with trastuzumab, along with an aromatase inhibitor.